fingolimod hydrochloride has been researched along with Retinal Dystrophies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegood, J; Chalfant, CE; LaVail, MM; Mandal, NA; Matthes, MT; Porter, H; Qi, H; Stiles, M; Sun, E; Tan, J; Yasumura, D | 1 |
1 other study(ies) available for fingolimod hydrochloride and Retinal Dystrophies
| Article | Year |
|---|---|
Sphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration.
Topics: Animals; Biosynthetic Pathways; Disease Progression; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Photoreceptor Cells, Vertebrate; Rats, Sprague-Dawley; Retinal Dystrophies; Sphingolipids; Sphingomyelin Phosphodiesterase | 2016 |